These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 8114747
1. Mutant cell lines unresponsive to alpha/beta and gamma interferon are defective in tyrosine phosphorylation of ISGF-3 alpha components. Loh JE, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Flavell RA. Mol Cell Biol; 1994 Mar; 14(3):2170-9. PubMed ID: 8114747 [Abstract] [Full Text] [Related]
2. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Watling D, Guschin D, Müller M, Silvennoinen O, Witthuhn BA, Quelle FW, Rogers NC, Schindler C, Stark GR, Ihle JN. Nature; 1993 Nov 11; 366(6451):166-70. PubMed ID: 7901766 [Abstract] [Full Text] [Related]
3. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Müller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, Harpur AG, Barbieri G, Witthuhn BA, Schindler C. Nature; 1993 Nov 11; 366(6451):129-35. PubMed ID: 8232552 [Abstract] [Full Text] [Related]
4. Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN-gamma signal-transduction pathways. Min W, Pober JS, Johnson DR. Circ Res; 1998 Oct 19; 83(8):815-23. PubMed ID: 9776728 [Abstract] [Full Text] [Related]
5. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta. Abramovich C, Shulman LM, Ratovitski E, Harroch S, Tovey M, Eid P, Revel M. EMBO J; 1994 Dec 15; 13(24):5871-7. PubMed ID: 7813427 [Abstract] [Full Text] [Related]
6. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line. Dovhey SE, Ghosh NS, Wright KL. Cancer Res; 2000 Oct 15; 60(20):5789-96. PubMed ID: 11059775 [Abstract] [Full Text] [Related]
7. Interferon alpha (IFN alpha) signaling in cells expressing the variant form of the type I IFN receptor. Colamonici OR, Domanski P, Krolewski JJ, Fu XY, Reich NC, Pfeffer LM, Sweet ME, Platanias LC. J Biol Chem; 1994 Feb 25; 269(8):5660-5. PubMed ID: 8119902 [Abstract] [Full Text] [Related]
8. Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta. Barbieri G, Velazquez L, Scrobogna M, Fellous M, Pellegrini S. Eur J Biochem; 1994 Jul 15; 223(2):427-35. PubMed ID: 8055912 [Abstract] [Full Text] [Related]
9. Induction of expression of interferon-stimulated gene factor-3 (ISGF-3) proteins by interferons. Kumar R, Korutla L. Exp Cell Res; 1995 Jan 15; 216(1):143-8. PubMed ID: 7529187 [Abstract] [Full Text] [Related]
10. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Sancéau J, Hiscott J, Delattre O, Wietzerbin J. Oncogene; 2000 Jul 13; 19(30):3372-83. PubMed ID: 10918594 [Abstract] [Full Text] [Related]
11. Role of STAT2 in the alpha interferon signaling pathway. Leung S, Qureshi SA, Kerr IM, Darnell JE, Stark GR. Mol Cell Biol; 1995 Mar 13; 15(3):1312-7. PubMed ID: 7532278 [Abstract] [Full Text] [Related]
12. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation. Novick D, Nabioullin RR, Ragsdale W, McKenna S, Weiser W, Garone L, Burkins C, Kim SH, Rubinstein M, Tepper MA, Arulanandam AR. J Interferon Cytokine Res; 2000 Nov 13; 20(11):971-82. PubMed ID: 11096454 [Abstract] [Full Text] [Related]
13. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Pang Q, Fagerlie S, Christianson TA, Keeble W, Faulkner G, Diaz J, Rathbun RK, Bagby GC. Mol Cell Biol; 2000 Jul 13; 20(13):4724-35. PubMed ID: 10848598 [Abstract] [Full Text] [Related]
14. Tyrosine phosphorylation is required for activation of an alpha interferon-stimulated transcription factor. Gutch MJ, Daly C, Reich NC. Proc Natl Acad Sci U S A; 1992 Dec 01; 89(23):11411-5. PubMed ID: 1280824 [Abstract] [Full Text] [Related]
15. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Kohlhuber F, Rogers NC, Watling D, Feng J, Guschin D, Briscoe J, Witthuhn BA, Kotenko SV, Pestka S, Stark GR, Ihle JN, Kerr IM. Mol Cell Biol; 1997 Feb 01; 17(2):695-706. PubMed ID: 9001223 [Abstract] [Full Text] [Related]
16. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1. Chang YJ, Holtzman MJ, Chen CC. Mol Pharmacol; 2004 Mar 01; 65(3):589-98. PubMed ID: 14978237 [Abstract] [Full Text] [Related]
17. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Schindler C, Shuai K, Prezioso VR, Darnell JE. Science; 1992 Aug 07; 257(5071):809-13. PubMed ID: 1496401 [Abstract] [Full Text] [Related]
18. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Li S, Labrecque S, Gauzzi MC, Cuddihy AR, Wong AH, Pellegrini S, Matlashewski GJ, Koromilas AE. Oncogene; 1999 Oct 14; 18(42):5727-37. PubMed ID: 10523853 [Abstract] [Full Text] [Related]
19. The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. Sakatsume M, Igarashi K, Winestock KD, Garotta G, Larner AC, Finbloom DS. J Biol Chem; 1995 Jul 21; 270(29):17528-34. PubMed ID: 7615558 [Abstract] [Full Text] [Related]
20. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex. Yokota S, Saito H, Kubota T, Yokosawa N, Amano K, Fujii N. Virology; 2003 Feb 01; 306(1):135-46. PubMed ID: 12620806 [Abstract] [Full Text] [Related] Page: [Next] [New Search]